Sellas Life Sciences Group Inc (SLS) earnings · $1.62B cap
These earnings events as JSON? API free 100/daySellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
This SLS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SLS revenue for 2023-12-31 was $0. Net income was -$37.3M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. SLS currently screens at market cap $1.62B.
When the next SLS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2022-12-31 to 2023-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full SLS research stays on the stock page; the tape stays on the quote page.
SLS earnings FAQ
What is SLS's latest net income?
Latest cached Sellas Life Sciences Group Inc (SLS) net income was -$37.3M. Statements: https://lician.com/financials/sls
What is SLS's latest diluted EPS?
Latest cached Sellas Life Sciences Group Inc (SLS) diluted EPS for Dec 31, 2023 was -$1.34.
What period does the latest SLS earnings print cover?
The latest cached Sellas Life Sciences Group Inc (SLS) earnings print covers Dec 31, 2023. The prior cached period on this page is Dec 31, 2022.
Where are SLS earnings listed?
Cached earnings facts for Sellas Life Sciences Group Inc (SLS) are listed at https://lician.com/earnings/sls. Statements: https://lician.com/financials/sls
Not investment advice.